|School||UCSF School of Medicine|
|Address||513 Parnassus Ave, Med Sci|
San Francisco CA 94143
|Tufts University||M.D.||School of Medicine||2005|
|National Institute on Aging (NIH)||2014
||2019||K23 Paul B. Beeson Career Development Award in Aging Research|
|UCSF Pepper Center||2014
||2015||Associate Scholar Genius Award |
|National Institute on Aging (NIH)||2013
|UCSF Pepper Center||2013
||2014||Pilot Award in Aging Research|
|Association of Specialty Professors||2013
||2015||T. Franklin Williams Scholar|
|UCSF Liver Center||2013
|UCSF Resource Allocation Program||2013
||2014||UCSF Pilot for Junior Investigator Award|
|American College of Gastroenterology||2012
||2015||Junior Faculty Career Development Award|
|American College of Physicians||2012
|American College of Gastrenterology||2011
||2012||Clinical Research Award|
|American Association for the Study of Liver Diseases||2011
||2012||Transplant Hepatology Fellowship|
|International Liver Transplantation Society||2011||Vanguard Award|
|Northern California Kaiser Permanente||2009
||2010||Sylvia Allison Kaplan Clinical Research Award|
|Tufts University School of Medicine||2005||Alpha Omega Alpha|
Dr. Jennifer C. Lai is a general and transplant hepatologist, specializing in treating patients with chronic viral hepatitis (both B and C), autoimmune disorders, and those with end-stage liver disease needing liver transplantation.
In addition to her clinical practice, she is actively engaged in patient-oriented clinical research within three major themes:
1) the application of core principles of geriatrics (i.e., frailty, disability, lag-time benefit) to patients with cirrhosis and liver transplant patients,
2) organ allocation and distribution, and
3) liver donor quality.
Dr. Lai is the principal investigator for the NIH-funded Functional Assessment in Liver Transplant (FrAILT) Study which aims to apply measures of frailty and functional status to patients with end-stage liver disease awaiting liver transplantation. Her central hypothesis is that applying principles of geriatric assessment to this population can improve our ability to better identify which patients are particularly vulnerable to adverse outcomes before and after liver transplantation. Her research lays the groundwork for therapeutic interventions to "pre-habilitate" patients awaiting liver transplantation to improve their outcomes and quality of life.
After earning her undergraduate degree from Stanford University and combined MD/MBA degrees from Tufts University, she completed residency at the New York Presbyterian Hospital-Columbia and gastroenterology and advanced/transplant hepatology fellowships at UCSF. She is a member of the American Association for the Study of Liver Diseases, American Society of Transplantation, American Gastroenterological Association, and American College of Gastroenterology. She has been recognized as a Fellow of the American College of Physicians (FACP). Dr. Lai is board certified in Internal Medicine, Gastroenterology, and Advanced/Transplant Hepatology.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.